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Introduction {#sec1}
============

Obesity-related metabolic diseases cause major public health problems. Dysregulation of the microbiome ([@bib177]) and the circadian clock have been implicated in the progression of these diseases ([@bib85]). Many physiological processes, including fatty acid (FA) and bile acid (BA) metabolism, as well as cytokine and corticosteroid secretion, are regulated by both circadian rhythms and microbiota. Remarkably, the composition and metabolic activity of commensal bacteria show diurnal variations that depend on the circadian clock ([@bib96], [@bib160], [@bib171]), feeding rhythms ([@bib160], [@bib161], [@bib170], [@bib185]), and the nutritional composition of the diet ([@bib90], [@bib170], [@bib185]). Vice versa, microbiota can feed back on clock gene expression in the host. Indeed, germ-free (GF) or antibiotic-treated mice show disturbed circadian clock gene expression in liver and intestine ([@bib19], [@bib64], [@bib90], [@bib115], [@bib117]). Moreover, conditions altering the composition of the microbiome, such as high-fat diet (HFD) ([@bib57]), obesity ([@bib92]), and Roux-en-Y gastric bypass surgery ([@bib164]) also affect host circadian clock gene expression ([@bib5], [@bib75], [@bib76]). However, effects of microbiome on the host circadian clock in peripheral tissues show striking inconsistencies.

To further study the relationship between the host-microbiota relationship and the circadian clock, we used RNA sequencing (RNA-seq) of conventionally raised (ConvR) and GF mice to compare temporal gene expression in liver, duodenum, ileum, and perigonadal white adipose tissue (WAT). We found that the molecular clock was globally unaffected, but genes involved in key metabolic processes exhibited an altered rhythmic expression in GF mice. Strikingly, we observed a feminization of gene expression (i.e., downregulation of male-biased and upregulation of female-biased genes) in the liver and WAT of GF male mice. In females, our analysis confirmed an attenuation of sexually dimorphic rhythmic gene expression and metabolic activities in GF mice. This was a consequence of altered sex-hormone and growth hormone (GH) signaling, likely due to the defective sexual maturation of GF mice. These results highlight the key role of the microbiota on the establishment of sexually dimorphic liver metabolism and tentatively elucidate several unexplained phenotypes of GF mice that are also known to be sexually dimorphic, such as resistance to liver cancer ([@bib55]), xenobiotic detoxification ([@bib28]), metabolic differences ([@bib122]), and poor reproduction ([@bib151]).

Results {#sec2}
=======

Global Alteration of Gene Expression in the Digestive Tract of GF Mice {#sec2.1}
----------------------------------------------------------------------

To study the impact of microbiota on host gene expression, we compared temporal gene expression in the liver, duodenum, ileum, and WAT of GF and ConvR male mice ([Figure S1](#mmc1){ref-type="supplementary-material"}A). The transcriptomes of GF and ConvR could be distinguished in the liver, duodenum, and ileum but less so in WAT ([Figure S1](#mmc1){ref-type="supplementary-material"}B). We first analyzed constitutive changes between GF and ConvR mice in the different tissues. In the duodenum and ileum of GF mice, most affected genes displayed a significant decrease in expression ([Figure S1](#mmc1){ref-type="supplementary-material"}C and [Table S1](#mmc2){ref-type="supplementary-material"}). Specifically, genes associated with immune response and immune cell mobility were downregulated in the intestine of GF mice ([Figure S1](#mmc1){ref-type="supplementary-material"}D). In the liver, we detected a significant alteration for genes involved in lipid and cholesterol metabolism, confirming the role of microbiota in these pathways ([@bib64]). In WAT, genes related to immune response were downregulated, consistent with previous reports ([@bib25]).

Microbiota Depletion Alters Rhythmic Gene Expression {#sec2.2}
----------------------------------------------------

Next, we quantified rhythmic gene expression in ConvR and GF mice (see [STAR Methods](#sec4){ref-type="sec"} and ([@bib7])) ([Figure 1](#fig1){ref-type="fig"}A and [Table S1](#mmc2){ref-type="supplementary-material"}). The analysis revealed that most rhythmic transcripts are unaffected (model 4). Interestingly, a higher proportion of genes gained rather than lost rhythmicity in the duodenum and ileum of GF mice (model 2). In the liver and WAT, this ratio was reversed ([Figures 1](#fig1){ref-type="fig"}B and 1C). Circadian clock and clock output genes showed only subtle changes in phase and amplitude of mRNA abundance across tissues ([Figures 1](#fig1){ref-type="fig"}D and [S1](#mmc1){ref-type="supplementary-material"}E--S1H). Most of the genes that lost rhythmicity in the duodenum of GF mice were associated with ribosome biogenesis, a rhythmically orchestrated process in the liver ([@bib152], [@bib173]), and glutamine metabolism, reported to correlate with colonization of the intestine ([@bib2]) ([Table S2](#mmc3){ref-type="supplementary-material"}). In the ileum, the genes that lost rhythmicity were involved in the organization of the extracellular matrix, potentially reflecting its rhythmic regeneration after its degradation by contacts with bacteria ([@bib161]). Moreover, genes involved in carbohydrate metabolism gained rhythmicity in the ileum of GF mice, suggesting that microbiota, known to regulate glucose transport and metabolism ([@bib42]), dampen rhythmic glucose metabolism in ConvR mice. In WAT of GF mice, the loss of rhythmicity in genes involved in cytokine signaling might reflect microbiota-dependent rhythmic inflammatory processes ([@bib25]). Meanwhile, genes associated with deoxyribonucleotide metabolism, a process showing increased activity during gut colonization ([@bib2]), gained rhythmicity in GF mice.Figure 1Gut Microbiota Alters Rhythmic Gene Expression in Peripheral Organs but Mildly Affects Clock Gene Expression(A) Alteration of rhythmic gene expression in male GF (GF♂) mice is assessed by model selection (model 1--5): black line, stable transcription; black wave, rhythmic transcription; red wave, rhythmic profiles with different rhythmic parameters (i.e., phase and/or amplitude).(B) Model distribution of all expressed genes in the examined organs. Coloring indicates the corresponding models as shown in (A); gray, genes not assigned to any specific model.(C) Heatmaps of normalized mRNA levels in male ConvR (ConvR♂) and GF♂ mice (red, high expression; green, low expression). Colored bars indicate the corresponding models. Black and white bars represent light conditions.(D) The assignment of circadian clock genes to their corresponding models shows that their temporal profiles are only mildly affected.(E) Liver genes with altered rhythmicity (models 2, 3, and 5) in GF mice are associated with metabolic and steroidogenic pathways and neurological disorders.

GF livers showed a loss of rhythmicity in genes involved in chromatin assembly and nucleosome assembly, including several histone and MCM proteins. These genes are induced during the S phase of the cell cycle ([@bib35]) and during liver regeneration after partial hepatectomy ([@bib58]), potentially explaining defective liver regeneration in GF mice ([@bib34]). Interestingly, several liver transcription factors (TFs) gained rhythmic expression in GF mice, including ChREBP (encoded by the *Mlxipl* gene), which could contribute to an increased number of rhythmic transcripts in these animals. Genes involved in polysaccharide, amino acid (AA), lipid, and steroid metabolism, in addition to drug metabolism, lost rhythmicity in GF animals ([Figure 1](#fig1){ref-type="fig"}E). Several of these biological functions are modulated in livers of GF mice ([@bib64], [@bib83], [@bib149], [@bib161]). Strikingly, the same functions are sexually dimorphic in mouse liver ([@bib97], [@bib181]), suggesting the involvement of bacteria colonization in maintenance of sexual dimorphism in liver.

Sex-Specific Gene Expression Is Damped in GF Mice {#sec2.3}
-------------------------------------------------

To analyze altered sexually dimorphic gene expression in GF mice, we first defined hepatic female- and male-biased genes ([STAR Methods](#sec4){ref-type="sec"} and [Table S3](#mmc4){ref-type="supplementary-material"}) and then studied their differential expression in ConvR and GF mice ([Figure 2](#fig2){ref-type="fig"}A). Remarkably, the genes upregulated in the liver of GF male mice were significantly enriched in female-biased genes, while those downregulated were enriched in male-biased genes ([Figures 2](#fig2){ref-type="fig"}B and 2D). The inverse observation in females confirmed an attenuation of sex-biased gene expression in livers of GF mice ([Figures 2](#fig2){ref-type="fig"}C and 2D). To substantiate this finding, we reanalyzed published data using GF and ConvR males under conventional chow diet ([@bib90]) or HFD ([@bib133]) ([Figures S2](#mmc1){ref-type="supplementary-material"}A, S2B, and S2F). Both datasets confirmed that male livers were feminized in the absence of microbiota. We also compared these sexually dimorphic gene expression signatures with additional conditions known to alter gut microbiota. When examining mice that grew up on an HFD ([@bib37]) and were then subjected to vertical sleeve gastrectomy (VSG) ([@bib120]), or fed with resistant starch ([@bib72]), we found that HFD ([@bib92]) led to a feminization of hepatic gene expression ([Figures S2](#mmc1){ref-type="supplementary-material"}C and S2F). Both VSG and resistant starch feeding change gut microbiota composition ([@bib72], [@bib164]) and reverse the HFD-induced feminization of obese animals ([Figures S2](#mmc1){ref-type="supplementary-material"}D--S2F). The observed feminization was not specific to the liver, as the sexually dimorphic WAT ([@bib181]) in male GF animals also showed a feminized expression pattern ([Figures S2](#mmc1){ref-type="supplementary-material"}G and S2H).Figure 2A Lack of Gut Microbiota Decreases Sex-Specific Gene Expression by Feminizing Male and Masculinizing Female Hepatic Gene Expression(A) Experimental design to detect sex-specific changes.(B) Volcano plot of differences in mRNA expression between ConvR♂ and GF♂ categorized by sex-biased expression in ConvR mice (ConvR♂ versus ConvR female \[ConvR♀\]). Colors indicate male-biased (blue), female-biased (red), and unbiased (gray) expressed genes.(C) Volcano plot of expression difference in mRNA expression between female GF (GF♀) and ConvR♀ mice. Color code is identical to (B).(D) Statistical analysis of male- and female-biased genes showing a significant inversion of sex-biased genes toward the opposite sex in GF mice.(E) Number of the shared differentially expressed genes (intersections size) between the four indicated contrasts. Lower heatmap indicates the enrichment for chromosomal location (Chr) for the corresponding intersection.(F) Expression changes of differentially expressed *Mup* genes in GF♂ mice as assessed by RNA-seq. Most *Mup* genes are downregulated in GF♂ mice. The highest expressed *Mup* in female liver (*Mup3*) is downregulated in GF♀ mice. Colored gene name indicates unbiased (black) and male-biased (blue) expression. Triangle indicates the direction of significant change in GF♂ (blue) and GF♀ (red) mice in comparison with ConvR.(G) Protein levels of MUP in the urine of GF♂ and GF♀ mice are significantly downregulated in male and female mice compared with their ConvR counterparts (each Tukey boxplot represents four independent biological replicates per condition). ^∗^p ≤ 0.05, ^∗∗∗^p ≤ 0.001.

To identify mechanisms involved in the establishment of sexual dimorphism by gut microbiota, we wondered whether sex-specific microbiota could explain sexually dimorphic gene expression. We profiled fecal microbiota of male and female mice during sex-specific cohousing and after a 2-week period when beddings across all cages were daily mixed. While beta diversity during sex separated housing conditions showed some statistical differences between male and female, individual variation was the main driver of this diversity ([Figures S2](#mmc1){ref-type="supplementary-material"}I and S2J). Indeed, no statistical difference in the individual microbiota composition was detectable after housing the animals with the same bedding material, confirming that cohousing of the animals has a major impact on gut microbiota composition and diversity. Therefore, it is likely that the complete lack of gut microbiota, rather than sex difference in microbiota, alters sex-dimorphic gene expression.

Genes on sex chromosomes were not likely involved in the attenuation of sexual dimorphism since the sex-biased genes localized on gonosomes (about 40%) were unchanged between ConvR and GF conditions ([Figure 2](#fig2){ref-type="fig"}E). Sex-specific genes were also enriched on chromosome 4, where the male-specific genes encoding mouse urinary proteins (MUPs) are located in two clusters ([@bib18]). Concordantly, the vast majority of *Mup* genes ([Figure 2](#fig2){ref-type="fig"}F) and MUP proteins in urine displayed reduced levels in both GF males and females ([Figure 2](#fig2){ref-type="fig"}G). Among the biological functions associated with sexually dimorphic genes altered in GF mice, lipid, cholesterol, and steroid metabolism, as well as xenobiotic detoxification, were the most prevalent ([Table S4](#mmc5){ref-type="supplementary-material"}).

Characterization of Signaling Pathways Involved in Damping of Liver Sexual Dimorphism in GF Mice {#sec2.4}
------------------------------------------------------------------------------------------------

To identify TFs regulating the observed attenuation of sexual dimorphism in GF mice, we performed TF-binding site analysis near (±500 bp) transcription start sites (TSSs) of sexually dimorphic genes ([STAR Methods](#sec4){ref-type="sec"}). Among the predicted TF activities showing differences between ConvR males and females, we focused on those with reduced sex-differential activity in GF animals ([Table S5](#mmc6){ref-type="supplementary-material"}). This identified the known sexually dimorphic GH-STAT5/BCL6 pathway and the associated TFs CUX2 and FOXA2 ([@bib157]), nuclear respiratory factor 1 (NRF1) and 2 (NRF2 also known as GABP, a member of the ETS family of TFs), aryl hydrocarbon receptor (AHR), and androgen receptor (AR) ([Figure S3](#mmc1){ref-type="supplementary-material"}A). Testosterone activates AR and thereby induces sex-specific postnatal DNA demethylation in mouse liver, which plays an important role in epigenetic imprinting of sexual dimorphism in the liver ([@bib136]). Interestingly, DNA binding of NRF1 and GABP strongly depends on DNA methylation in mouse embryonic stem cells ([@bib41]), which potentially explains sex- and methylation-dependent transcriptional activity of NRF1 and GABP ([@bib182]). Likewise, AHR transcriptional activation is sex-biased ([@bib89]), inhibits GH signaling ([@bib123]), and initiates crosstalk with sex-hormone signaling through direct interaction with estrogen receptor (ER) ([@bib124]). While levels of 17β-estradiol (E2) have not been previously measured in GF animals, sexually dimorphic circulating testosterone is strongly blunted in GF animals ([@bib107], [@bib183]), potentially explaining the differential activation of these TFs. To confirm such deregulation of sex hormones, we measured testosterone and E2 in serum from ConvR and GF males and females. We found that, in addition to testosterone, sexual dimorphism in E2 levels was also blunted, suggesting a potential role of sex hormones in the loss of sexually dimorphic activation of signaling pathways in GF mice ([Figures 3](#fig3){ref-type="fig"}A and 3B).Figure 3Sex Hormones and the GH Signaling Network Are Perturbed in GF Mice(A and B) Serum levels of testosterone (A) and E2 (B) in male and female ConvR and GF mice.(C) Circulating GH total secretion, peak number, and levels in male and female ConvR and GF mice.(D) Representative examples of temporal profiles of GH secretion in ConvR♂, GF♂, ConvR♀, and GF♀ animals.(E) Enrichment analysis of FOXA1, FOXA2, BCL6, CUX2, and STAT5 (male and female specific) target genes for differentially expressed genes of indicated contrasts (♂ = GF♂ versus ConvR♂; ♀ = GF♀ versus ConvR♀; ConvR = ConvR♂ versus ConvR♀; GF = GF♂ versus GF♀). Target genes have been identified by published chromatin immunoprecipitation sequencing (ChIP-seq) data.(F) Phosphorylation of STAT5 (Tyr694) in male and female ConvR and GF mice.(G) Hepatic mRNA and protein levels of the other GH-dependent TFs BCL6 and CUX2 that are involved in sex-dimorphic gene expression for the indicated conditions.(H) Experimental design to mimic male-specific GH pulses in GF mice.(I) Volcano plot of expression difference in mRNA expression between GH-injected and vehicle-injected GF male mice show a rescue in sex-biased gene expression.(J) Enrichment analysis of male- and female-specific genes (♂ biased, ♀ biased) or repressed or induced genes in GF mice (down or up in GF♂) for differentially expressed genes of the contrast GH- versus vehicle-injected GF♂ mice.(K) Experimental design of an *in vitro* system of primary hepatocytes treated with sera of different sources (ConvR♂, ConvR♀, and GF♀).(L) Volcano plot of expression difference in mRNA expression of female hepatocytes treated with GF♀ serum versus ConvR♀ serum. Color code corresponds to (B).(M) Enrichment analysis of male- and female-specific genes (♂ biased, ♀ biased) for differentially expressed genes of the indicated contrasts (serum treatment: ConvR♂ versus ConvR♀ or GF♀ versus ConvR♀) in female hepatocytes.(N) Cartoon depicting the experimental design to evaluate the effect of a tonic GH treatment.(O) Number of differentially expressed genes in function of an adjusted p value threshold for the indicated contrast. GH treatment diminished the number of differentially expressed genes between female hepatocytes treated with GF♀ serum and ConvR♀ serum.(P) Enrichment analysis of male- and female-specific genes (♂ biased, ♀ biased) for differentially expressed genes between GH-treated versus untreated female hepatocytes.All boxplots represent at least 12 independent biological replicates per condition, except for (G), for which at least six biological replicates were used. ^∗^p ≤ 0.05, ^∗∗^p ≤ 0.01, ^∗∗∗^p ≤ 0.001. All boxplots are Tukey boxplots.

Liver sexual dimorphism is mainly regulated through the secretory pattern of GH by the pituitary male-specific pulsatile secretion versus more continuous secretion in females. This difference leads to sex-specific activation of GH signaling, as reflected in the activation and phosphorylation of the STAT5 TF, namely high and transient phosphorylation in males versus low and constant phosphorylation in females ([@bib97], [@bib188]). We envisioned that differential GH-STAT5 activation might underlie the decreased liver sexual dimorphism of GF mice. Thus, we first measured GH receptor (GHR) expression, which showed no significant differences in ConvR versus GF animals at protein levels and only a slight reduction in expression in females at the mRNA level ([Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C). We therefore speculated that gut microbiota could affect sexually dimorphic GH secretion. Surprisingly, both GF males and females secreted low levels of GH, and GF females displayed a male-like temporal secretion pattern, which was characterized by a more pulsatile secretion with a lower number of peaks ([Figures 3](#fig3){ref-type="fig"}C and 3D). This disturbed GF secretion therefore likely contributes to the damped sexual dimorphism of the liver.

We next studied downstream signaling pathways and measured the enrichment of male- and female-specific STAT5 target genes ([@bib188]) among up- and downregulated genes in GF mice. We found a significant enrichment of STAT5-regulated genes among upregulated genes in GF males, which coincided mainly with genes usually expressed in female liver and enriched for female STAT5 sites ([Figure 3](#fig3){ref-type="fig"}E). We further observed a characteristic bursty activation pattern of STAT5 in male ConvR mice, presumably reflecting male-specific GH secretion. Moreover, while GF males displayed a female-like baseline phosphorylation, GF females exhibited constant low phosphorylated STAT5, confirming the overall altered sexually dimorphic STAT5 activity ([Figures 3](#fig3){ref-type="fig"}F and [S3](#mmc1){ref-type="supplementary-material"}D).

To establish causality between the observed altered GH secretion and the attenuated sexual dimorphism in GF mice, we mimicked male-specific GH pulses in GF males with two daily GH injections ([@bib62]) ([Figure 3](#fig3){ref-type="fig"}H). This treatment globally restored sexually dimorphic liver gene expression ([Figures 3](#fig3){ref-type="fig"}I, 3J, and [S3](#mmc1){ref-type="supplementary-material"}G). We evaluated the effect of GH in females *in vitro* by incubating primary hepatocytes from female mice with serum from female (ConvR and GF) and male (ConvR) mice in the presence or absence of constant level of GH. This *in vitro* approach recapitulated the *in vivo* observation that sexual dimorphism is altered in GF mice, confirming that circulating factors play a key role ([Figures 3](#fig3){ref-type="fig"}K--3M and [S3](#mmc1){ref-type="supplementary-material"}H). In addition, continuous treatment with GH mitigated the masculinized gene expression profile of female hepatocytes treated with GF female serum, establishing causality between altered GH secretion and loss of sexual dimorphism in GF female mice ([Figures 3](#fig3){ref-type="fig"}N--3P and [S3](#mmc1){ref-type="supplementary-material"}I).

Regulation of *Bcl6* Transcription through GH-Regulated Antisense Transcription {#sec2.5}
-------------------------------------------------------------------------------

The male-biased repressor BCL6 and the female-biased activators FOXA1 (HNF3α), FOXA2 (HNF3β), ONECUT2 (HNF6β), and repressor CUX2 also play a key role in sexually dimorphic gene expression ([@bib33], [@bib111], [@bib157], [@bib188]). Among these TFs, *Bcl6* and *Cux2* show the most pronounced sexually dimorphic expression and are altered in GF mice at both mRNA and protein levels ([Figures 3](#fig3){ref-type="fig"}G, [S3](#mmc1){ref-type="supplementary-material"}E, and S3F). Binding sites for these TFs were enriched in sex-biased genes that are upregulated in GF mice ([Figure 3](#fig3){ref-type="fig"}E). Among them, BCL6, in association with STAT5, was the best predictor for the decreased sexual dimorphism of GF mice. *Bcl6* expression is regulated by GH at the transcriptional elongation level ([@bib112]). Quantification of the transcripts at the *Bcl6* locus revealed, surprisingly, two non-annotated antisense (AS) transcripts, one starting at the TSS (*as-2*) and one inside the gene body (*as-1*) ([Figure 4](#fig4){ref-type="fig"}A). These two transcripts overlapped with the previously described highly transcribed region of the gene in female, regulated by GH ([@bib112]). In fact, all sense intronic and exonic signals were correlated across the different conditions. However, while *as-2* was not correlated with the sense signals, *as-1* was anti-correlated with *Bcl6* exons and introns ([Figures 4](#fig4){ref-type="fig"}B and 4C), suggesting that the *as-1* transcript interferes with the elongation of the sense transcript, potentially by modulating the sense transcript dynamics by AS transcription ([@bib22]). Analysis of chromatin states near the *as-1* TSS revealed the presence of a cryptic promoter ([Figure S3](#mmc1){ref-type="supplementary-material"}J). The 3′ end of the *as-1* transcript coincided with a male-specific DNase I hypersensitive site and STAT5 binding site, which disappeared under chronic GH treatment mimicking female GH secretion ([Figure S3](#mmc1){ref-type="supplementary-material"}J). Interestingly, STAT5 binding to the *Bcl6* gene represses its transcription ([@bib99]), potentially explaining the repression of *as-1* in males and the inhibition of *Bcl6* elongation by GH ([@bib112]).Figure 4Expression of the Male-Specific Repressor *Bcl6* Anti-correlates with a GH-Responsive AS Transcript(A) RNA-seq read mapping to the *Bcl6* gene locus. The tracks are color coded for the indicated conditions. The log2 normalized read count versus chromosomal position is plotted across the y axis for sense (upper part) and AS (lower part) transcription. The schematic represents exons and introns of *Bcl6* (ss) and the two AS transcripts (*as-1*, *as-2*).(B) Correlation matrix based on Pearson\'s rank correlation coefficient test between the expression levels of the indicated exon, intron, and AS transcript. Colors indicate positive (blue) and negative (red) correlation. Size of the circles correspond to more significant p values, only correlation with an adjusted p value lower than 0.05 are depicted with a circle.(C) Normalized read counts per exon (upper graph), intron, and AS transcript (lower graph) of the *Bcl6* gene locus in liver of ConvR♂ (dark blue), ConvR♀ (dark red), GF♂ (light blue), and GF♀ mice (light red).(D) Normalized read counts of GH-treated and vehicle-injected GF♂ mice for sense (left) and AS-1 transcript (right).(E) Experimental design.(F) Normalized read counts of GH- and vehicle-treated female hepatocytes under GF♀ serum incubation for sense (left) and antisense-1 transcript (right).(G) Changes in sense and AS transcript levels between ConvR♂ versus ConvR (left), GF♂ versus ConvR♂ (middle), and GF♀ versus ConvR♀ (right). Significantly upregulated and downregulated genes on the level of Δsense--Δanti-sense are shown in red (false discovery rate\<0.01 and logFC~interaction~ \> 1). Gene names are depicted for genes with opposite behavior in the x and y axis (logFCx \> 0.5 and logFCy \< −0.5) or (logFCx \< −0.5 and logFCy \> 0.5). Globally, only *Bcl6* showed robust differences between sense and AS transcript levels across all conditions indicating that a sex-specific AS transcript that potentially regulates sex-biased expression of a gene is unique.All boxplots represent at least 12 independent biological replicates per condition, except for (F) for which three biological replicates were used. ^∗^p ≤ 0.05, ^∗∗^p ≤ 0.01, ^∗∗∗^p ≤ 0.001. All boxplots are Tukey boxplots.

GH injection in GF male mice decreased *as-1 Bcl6* transcript, whereas the sense transcript increased its expression ([Figure 4](#fig4){ref-type="fig"}D). Conversely, female hepatocytes treated with GF female serum decreased sense transcript levels upon GH treatment, while low *as-1* expression was unaltered. These results demonstrate the regulation of *Bcl6* by GH and indicate an involvement of *as-1* transcript in the regulation of *Bcl6* sense transcript ([Figures 4](#fig4){ref-type="fig"}E and 4F). The sex-specific regulation of the *as-1* transcript thus potentially provides a novel mechanism regulating sexually dimorphic gene expression. As such internal AS transcripts are quite common in mouse, we sought for additional similarly regulated sexually dimorphic genes in the liver. However, no additional transcripts showing similar sexually dimorphic sense/AS transcript levels were found, making *Bcl6* unique among sexually dimorphic genes ([Figure 4](#fig4){ref-type="fig"}G).

Impact of Microbiota on the Sexually Dimorphic Metabolome {#sec2.6}
---------------------------------------------------------

We next analyzed the impact of microbiota on sex-dimorphic metabolomes in liver and serum from ConvR and GF male and female mice. The observed sexual dimorphism in metabolite levels was markedly decreased in GF conditions ([Figures 5](#fig5){ref-type="fig"}A and 5B); notably, female-biased metabolites were upregulated in GF males and male-biased metabolites downregulated in both liver and serum ([Figures 5](#fig5){ref-type="fig"}C and [S4](#mmc1){ref-type="supplementary-material"}A). Sexual dimorphism was also diminished in GF females, albeit to a lower extent ([Figures 5](#fig5){ref-type="fig"}C and [S4](#mmc1){ref-type="supplementary-material"}B). To identify metabolic pathways with a microbiota-dependent sex-biased profile, we calculated a proxy for metabolic pathway activity and tested for statistical differences across all conditions ([Table S6](#mmc7){ref-type="supplementary-material"}). This identified three clusters of interconnected metabolic pathways. The first cluster involves folate (vitamin B9), purine, and pyrimidine metabolism ([Figures 5](#fig5){ref-type="fig"}D and [S4](#mmc1){ref-type="supplementary-material"}D). Folate and its metabolite DHF showed higher levels in ConvR male than in female mice, which was attenuated in GF condition. The male-biased concentration correlated with male-biased mRNA expression of the folate transporter SLC19A1 (RFC1) and the key enzyme for purine metabolism MTHFD2 (methylenetetrahydrofolate dehydrogenase and cyclohydrolase) ([@bib16]). Testosterone might be the driving force in establishing sexual dimorphism for folate metabolism, as it regulates MTHFD2 ([@bib143]). Microbiota is an important supplier of *de novo* synthesized folate to the host ([@bib87]), which likely led to the lower levels of folate and DHF in GF male mice. Increased concentrations in purine (inosine monophosphate, AMP, and guanosine monophosphate \[GMP\]) and pyrimidine (orotic acid and uridine monophosphate \[UMP\]) derivatives in ConvR male mice were slightly affected in absence of gut microbiota. The trifunctional key enzyme CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase) for pyrimidine synthesis ([@bib121]) was expressed in a male-biased manner, potentially leading to the increased UMP concentration in males. Moreover, the known activation of the pentose phosphate pathway by testosterone ([@bib71]) likely increases the synthesis of ribose and boosts AMP, GMP, and UMP synthesis.Figure 5Gut Microbiota Modulates the Sex-Dimorphic Metabolome(A and B) Principal-component analysis score plots of mass spectroscopy-based metabolic profiling of male (♂) and female (♀) ConvR and GF mice in liver (A) and serum (B).(C) Enrichment analysis of sex-biased metabolites in the upregulated (dark blue and red) and downregulated (light blue and red) fractions of metabolites in GF animals (GF versus ConvR) in the indicated tissue (liver or serum).(D--F) Schematic depicting regulation by sex and microbiota for folate, purine, and pyrimidine metabolism (D), glycolysis and FA oxidation (E), and the metabolic network of glutathione (GSH, methionine, PL, and BA) (F). Metabolites and genes involved in the steps where genes or metabolites showing sex-biased or microbiota-dependent changes. All gene names and metabolites are color coded for male-biased (blue), female-biased (red), and sex-unbiased (black) levels in the liver. The triangles that follow a gene or metabolite name indicate the direction of change in GF versus ConvR male (blue) and female (red) mice.(G) Sex-biased rhythmicity in gene expression was assessed by model selection (models 1--5) in both ConvR and GF mice: black line, stable transcription; black wave, rhythmic transcription; red wave, rhythmic profiles with different rhythmic parameters.(H) Heatmap of normalized mRNA levels in ConvR♂ and GF♂, and ConvR♀ and GF♀, across a day. Colored bars indicate the corresponding sex-specific models (2--5) in ConvR mice. Black and white bars on the bottom represent light conditions.(I and J) Heatmaps of relative metabolite levels in liver (I) and serum (J) sorted by the sex-specific models 2--5.(K) Fraction of genes corresponding to models 1--5 in ConvR and their assigned model in GF mice. The blue color in each box represents the fraction size of genes between ConvR and GF mice, with darkest blue corresponding to highest fraction.(L and M) Fraction of metabolites that are assigned to specific models for ConvR and GF mice in liver (E) and serum (F).(N--P) Feeding (N) and drinking (O) rhythms are not different between ConvR and GF mice (p \> 0.05). Locomotor activity is higher activity in ConvR♀ mice (p \< 0.001) but not different from males under GF conditions (P). Error bars represent SEM.

A second pathway cluster involves glycolysis and FA oxidation ([Figures 5](#fig5){ref-type="fig"}E and [S4](#mmc1){ref-type="supplementary-material"}E). Females exhibited increased *Hexokinases* (*Hks*), but decreased *Glucose-6-phosphatase* (*G6pc*) mRNA levels in comparison with male animals. This opposing sexually dimorphic expression pattern correlates with increased G6P levels. However, synthesis of acetyl-coenzyme A (CoA) is inhibited by an increased expression of *Pyruvate Dehydrogenase Kinases* (*Pdk1*, *Pdk2*) in females due to sexually dimorphic GH signaling ([@bib74]). Furthermore, AMPK inhibits such GH regulation of *Pdk* expression. We observed a lower phosphorylation of AMPK in females independently of microbiota ([Figure S4](#mmc1){ref-type="supplementary-material"}C), probably due to significantly decreased AMP levels ([Figures 5](#fig5){ref-type="fig"}D and [S4](#mmc5){ref-type="supplementary-material"}D) that might further reinforce the inhibition of acetyl-CoA production and thus *de novo* lipogenesis in females ([@bib56]). Decreased lipogenesis in females would be in line with the reported female-biased increase in mitochondrial activity and lipid β-oxidation ([@bib65]), and potentially reflects the positive effect of GH on these activities ([@bib69]). We used carnitine derivatives as a readout of mitochondrial activity ([@bib78]). Females showed lower levels of malonylcarnitine and a global increase of acylcarnitines in comparison with males, indicating increased mitochondrial activity and β-oxidation, respectively. What might be the cause of the observed sex bias in carnitine levels? Carnitine can originate from food or *de novo* synthesis ([@bib137]). The high level of carnitine in females is likely caused by E2 regulation of the main carnitine transporter SLC22A5 (OCTN2) ([@bib172]). We found key enzymes of the *de novo* synthesis of carnitine to be expressed in a female-biased manner, thereby reinforcing mitochondrial activity. In addition, microbiota is able to metabolize and synthesize carnitine ([@bib137]) and plays a role in its absorption and availability. Consistent with these reports, we detected low levels of carnitine in GF mice. Interestingly, ConvR females showed high levels of the atherosclerosis-associated metabolite trimethylamine N-oxide (TMAO), likely produced by the female-specific Flavin-containing Monooxygenase 3 (FMO3) from carnitine. Altogether, our data corroborated the reported sexual dimorphism in energy homeostasis ([@bib110]) and highlighted the role of microbiota in this pathway.

Finally, a cluster containing glutathione (GSH), AA, phospholipid (PL), and BA metabolism was profoundly sexually dimorphic and modulated by microbiota ([Figures 5](#fig5){ref-type="fig"}F and [S4](#mmc1){ref-type="supplementary-material"}F--S4I). GH affects methionine and GSH metabolism ([@bib23]), explaining the sex bias in this pathway. In addition, E2 increases GSH peroxidase activity and peroxide production ([@bib129]), potentially leading to the observed higher GSH oxidation in males. Interestingly, colonization of the gut was shown to influence host intestinal GSH metabolism ([@bib106]), explaining the generally lower levels of metabolites in this pathway in GF mice. Sexually dimorphic AA metabolism affects taurine and BA metabolism; these pathways are subject to regulation by GH ([@bib144]) and microbiota ([@bib145]). Consequently, taurine-conjugated BAs that inhibit farnesoid X receptor (FXR) activity ([@bib145]) were increased in GF mice ([Figures S4](#mmc1){ref-type="supplementary-material"}G and S4H), probably repressing genes involved in BA synthesis and cysteine sulfinic acid decarboxylase, the rate-limiting enzyme of taurine metabolism. We also observed that PLs were globally higher in males ([Figure S4](#mmc1){ref-type="supplementary-material"}I). High PLs are correlated with male-biased expression of Choline Phosphotransferase 1 (CHPT1), whereas the phospholipase PLA2G16 involved in the hydrolysis of these PL ([@bib166]) showed a female-biased expression. Through the metabolism of choline ([@bib142]), gut microbiota affected choline absorption and transport, globally modulating PL in GF mice. All three metabolic clusters discussed here exemplify the regulation of sexually dimorphic liver metabolism by the microbiota through direct impact on nutrient metabolism and transport, but also indirectly through the modulation of GH and sex-hormone signaling.

GF Mice Showed an Attenuated Sexual Dimorphism in Rhythmic Gene Expression and Metabolome {#sec2.7}
-----------------------------------------------------------------------------------------

Although sexual dimorphism of liver gene expression was extensively studied in animal models ([@bib97]), little is known about the influence of sex on rhythmic gene expression. We thus performed a genome-wide comparative analysis of sexually dimorphic liver gene expression under ConvR and GF conditions ([Figure 5](#fig5){ref-type="fig"}G). While 71% of all rhythmic genes were rhythmic in both sexes in ConvR mice (model 4), 9% of the genes were rhythmically expressed only in males (model 2, red) and 16% only in females (model 3). Furthermore, 4% were diurnally expressed in both sexes with different phases or amplitudes (model 5) ([Figure 5](#fig5){ref-type="fig"}H). These sex-specific rhythms were mainly involved in steroid hormone and drug metabolism in males (model 2) and protein transport and cell signaling in females (model 3) ([Table S4](#mmc5){ref-type="supplementary-material"}). Interestingly, genes exhibiting differentially rhythmic parameters between male and female (model 5) were enriched for circadian core clock genes. Some of these genes, namely *Cry1*, *Npas2*, *Nr1d2*, and *Nfil3*, showed a higher amplitude in females ([Figures S5](#mmc1){ref-type="supplementary-material"}A--S5C). Surprisingly, when we studied these sex-specific rhythmic genes in GF mice, we found that a majority lost their sex-biased rhythmic expression and became similar in males and females ([Figures 5](#fig5){ref-type="fig"}K, [S5](#mmc1){ref-type="supplementary-material"}D, and S5E). These observations indicate that sex-specific rhythmic mRNA expression was also influenced by the microbiome.

Since such rhythmically expressed genes likely influence metabolism, we studied the rhythmicity of serum and liver metabolomes under different conditions ([Figures 5](#fig5){ref-type="fig"}I and 5J and [Table S6](#mmc7){ref-type="supplementary-material"}). Around 34% of metabolites were found to oscillate in abundance in the liver and 20% in the serum. Interestingly, while 55% of all rhythmic liver metabolites were rhythmic in both sexes in ConvR mice (model 4), only 29% were rhythmic in the serum. These differences may reflect the influence of sexual dimorphism in the production of serum metabolites by additional tissues, including sexual organs. While 11% of the metabolites were rhythmic in males only in the liver (model 2), 32% were rhythmic in the serum. Meanwhile, an equal proportion of 31% and 32% of measured metabolites were rhythmic exclusively in female liver and serum (model 3), respectively. Similar to what we observed for mRNA expression, this sexual dimorphism was strongly damped in GF mice, with most of these metabolites becoming rhythmic in both sexes ([Figures 5](#fig5){ref-type="fig"}L and 5M). Altogether, these data further corroborate that microbiota control sexually dimorphic rhythmic gene expression and metabolism.

As feeding rhythms strongly affect rhythmic gene expression, we performed a behavioral phenotyping. All groups of mice showed similar feeding and drinking rhythms ([Figures 5](#fig5){ref-type="fig"}N and 5O). We also reproduced the described sexual dimorphism on locomotor activity ([@bib21]). Strikingly, the increased activity of ConvR females was lost in GF females, the latter thus showing a similar activity pattern as males ([Figure 5](#fig5){ref-type="fig"}P).

To characterize mechanisms underlying these changes, we performed TF-binding site analysis near TSSs of the sexually dimorphic rhythmic genes. Among the enriched TF-binding sites showing a predicted sexually dimorphic rhythmic activity in ConvR mice that is attenuated in GF mice, we noted the presence of consensus sequences for numerous receptors of hormones or metabolites ([Table S5](#mmc6){ref-type="supplementary-material"}). In males, motifs for AR, AHR, and the nuclear receptor NR6A1, which shares its core DNA-binding motif with the xenobiotic receptors PXR and CAR ([Figure S5](#mmc1){ref-type="supplementary-material"}F), showed a male-specific rhythmic activity in ConvR but not in GF mice ([Figure S5](#mmc1){ref-type="supplementary-material"}G). Conversely, in females, the Estrogen-Related Receptors α (ESRRA), sharing its DNA-binding motif with the Estrogen Receptor α (ERα) ([@bib167]), HNF1A and KLF4 displayed a rhythmic activity only in ConvR females, but in both sexes in GF conditions ([Figure S5](#mmc1){ref-type="supplementary-material"}H). Rhythmic AR activation was likely a consequence of rhythmic testosterone secretion, and testosterone levels lose their sexual dimorphism in GF mice ([Figure 3](#fig3){ref-type="fig"}A). This is also likely true for ERα and E2 ([Figure 3](#fig3){ref-type="fig"}B). While rhythmic KLF4 expression has never been reported, KLF3, which shares the same DNA-binding motif and is more highly expressed, has been found rhythmic ([@bib173]). Both of these TFs preferentially bind methylated DNA ([@bib153]) and are therefore likely more active in females due to the absence of testosterone-induced DNA demethylation ([@bib136]). HNF1A is crucial for GH signaling ([@bib88]) and likely participates in female-specific gene expression, as shown for the *Cyp2c12* gene in rat ([@bib174]). Male mice are more sensitive to AHR ligands ([@bib89], [@bib130]) and AHR activation is time and circadian clock dependent ([@bib132], [@bib159]). The same holds for PXR and CAR, which are also more efficiently activated in males ([@bib4]) and clock dependent ([@bib51], [@bib80]). Moreover, both pathways are stimulated by microbiota-derived molecules and metabolites ([@bib116], [@bib168], [@bib186]). By looking at sex-biased and rhythmic metabolites in ConvR and GF mice, we identified AHR modulators such as picolinic acid, kynurenine, and daidzein, as well as PXR modulators such as indole propionate (IPA), β/γ tocopherol, and ferulate ([Figure S5](#mmc1){ref-type="supplementary-material"}I). To test the involvement of these receptors, we incubated female primary hepatocytes with different types of sera. Sera from ConvR females induced a higher activation of both the AHR and PXR-related DNA motifs compared with ConvR male and GF female sera ([Figure S5](#mmc1){ref-type="supplementary-material"}J). It is therefore likely that both the hormone disturbance and differential metabolism of food-derived molecules contribute to the alteration of sexually dimorphic rhythmic gene expression in GF mice.

Microbiota-Derived Metabolites Affect Sexual Maturation {#sec2.8}
-------------------------------------------------------

What causes attenuated sexual dimorphism and altered action of testosterone, E2, and GH in GF animals? Sexual dimorphism in the liver appears during puberty ([@bib31]) when sex hormones imprint sex-specific and pulsatile GH secretion patterns ([@bib61]). Given the significant impact of the microbiome on sexual dimorphism of liver gene expression, microbiota-derived metabolites appear attractive agents to interfere with sexual development and the imprinting of GH secretion. Several signaling pathways regulated by microbiota-derived metabolites are particularly interesting. These include the activation of AHR and PXR by bacteria-derived molecules ([@bib116], [@bib168], [@bib186]) and the activation of FXR or TGR5 ([@bib145]) and PXR ([@bib154]) by BA. Indeed, in addition to their impact on liver metabolism, AHR ([@bib67]), its activator (e.g., dioxin) ([@bib128]), PXR, and its agonist PCN ([@bib187]) also play a role in the maturation of sexual organs. The same holds for BA ([@bib13], [@bib109]). Therefore, we speculated that the differential activation of these pathways in GF mice during the prepubertal period could participate in establishing sexual dimorphism in the liver. Indeed, our analysis of the liver transcriptome in male *Ahr* ([@bib162]) and *Fxr* ([@bib60]) knockout (KO) mice revealed a feminization of gene expression ([Figures 6](#fig6){ref-type="fig"}A, 6B, and 6D), while *Pxr* KO mice partly showed a masculinization ([Figures 6](#fig6){ref-type="fig"}C and 6D). Analysis of the expression of up- and downregulated genes in *Ahr*, *Fxr*, and *Pxr* KO mice in GF animals revealed that AHR-regulated genes showed an expression in GF mice similar to that observed in *Ahr* KO mice, whereas the opposite is observed in *Pxr* KO animals ([Figures 6](#fig6){ref-type="fig"}E and [S6](#mmc1){ref-type="supplementary-material"}A). A less significant directional change in GF mice was observed for genes deregulated in *Fxr* KO mice ([Figures 6](#fig6){ref-type="fig"}E and [S6](#mmc1){ref-type="supplementary-material"}A). These analyses suggest that the activation of AHR and PXR signaling pathways is increased and decreased in GF mice, respectively, corroborating that *Ahr* deletion is associated with loss of sexual dimorphism ([@bib59]) and PXR activation decreases testosterone secretion ([@bib187]). It therefore appears likely that the modified activation of AHR and PXR during the prepubertal period is responsible for the attenuated sexual dimorphism in GF mice. Concordantly, male GF mice conventionalized at 5 weeks of age showed increased expression of female-biased genes compared with mice conventionalized just after birth ([Figures S6](#mmc1){ref-type="supplementary-material"}B and S6E). Moreover, treatment with low-dose penicillin (LDP), which alters microbiota during early ages ([@bib37]), induces a feminization of both male and female liver gene expression ([Figures 6](#fig6){ref-type="fig"}F, 6G, and 6I). We observed a similar increase of female gene expression by treatments with other antibiotics such as amoxicillin and tylosin in females ([Figures S6](#mmc1){ref-type="supplementary-material"}C--S6E). This effect persists in female mice transplanted with fecal microbiota from LDP animals ([Figures 6](#fig6){ref-type="fig"}H and 6I). These observations suggest that changes in microbiota composition cause the hepatic feminization rather than the antibiotic treatment itself. Interestingly, LDP-treated males exhibited increased and decreased activation, respectively, of the AHR and PXR pathways, exactly as in GF mice ([Figures S6](#mmc1){ref-type="supplementary-material"}F and S6G).Figure 6Microbiota-Depleted Mice Show Differential Activation of Xenobiotic Receptors and Alteration in Sexual Development(A--C) Changes in hepatic gene expression (log2FC) and adjusted p values of *Ahr* KO (A), *Fxr* KO (B), and *Pxr* KO (C) mouse models presented as a volcano plot.(D) Adjusted p value for the enrichment of male- and female-biased genes in the indicated receptor KO model.(E) Heatmap illustrating the statistical overrepresentation of target genes from different xenobiotic sensing nuclear receptors in differentially expressed genes of GF♂ mice liver (GF♂ versus ConvR♂). Target genes have been defined as significantly up- or downregulated in the respective KO model.(F--H) Volcano plots depicting sex-biased hepatic gene expression across different conditions; for plot details see (A)--(C). (F and G) LDP-treated male (F) and female (G) animals versus their untreated counterparts. (H) Comparison between transfaunation of cecal microbiota into GF♀ mice from LDP-treated and -untreated animals.(I) Adjusted p value for the enrichment of male- and female-biased genes under the indicated antibiotics treatment.(J--L) GF mice show an alteration in spermatid differentiation. (J) Periodic acid--Schiff (PAS)-stained sections of testis from ConvR (left) and GF mice (middle and right) show that more seminiferous tubules of GF animals lack spermatids (white arrows) (right) than in their ConvR counterparts (left). (K) Tukey boxplots of at least five animals per group quantifying this difference (p \< 0.05, Mann-Whitney U test). (L) Heatmap illustrating the statistical overrepresentation of marker genes of different stages of spermatogenesis in differentially up- or downregulated genes of testis in GF animals.(M and N) GF mice present defects in follicle organization. (M) PAS-stained sections of follicles from ConvR (left) and GF mice (middle and right) show severe effects on the theca (Th) organization (left and right) and disorganization of some follicles in their granulosa (Gr) in GF animals. (N) Statistical overrepresentation of gene markers for fetal germ cells to oocyte development indicate defects in oocytes of GF mice.Scale bars, 100 μm (lower magnification) and 320 μm (higher magnification).

Therefore, we hypothesized that activation of specific cell signaling pathways by microbiota-derived molecules during the prepubertal period is crucial for sexual maturation and downstream metabolism. We thus studied gene expression and morphology of the gonads of GF mice. Testis seminiferous tubules from GF male mice showed a significantly lower proportion of fully differentiated spermatids compared with ConvR males ([Figures 6](#fig6){ref-type="fig"}J and 6K). This was confirmed by the lower expression of genes specific to round and later spermatids, corroborating a deficient sexual maturation of GF males ([Figure 6](#fig6){ref-type="fig"}L, [Table S7](#mmc8){ref-type="supplementary-material"}). In females, the organization of growing follicles was compromised, with disorganized granulosa cells and the presence of round-nuclei theca cells ([Figure 6](#fig6){ref-type="fig"}M). This disorganization was associated with the downregulation of genes specific to the late development stage and mature oocytes, confirming the disorganized follicular development in GF females ([Figure 6](#fig6){ref-type="fig"}N). Interestingly, both GH ([@bib70], [@bib184]) and *Ahr* ([@bib8], [@bib14]) deficiencies lead to comparable deficient sexual maturation, suggesting that both pathways could be involved in the appearance of this phenotype.

Hepatic expression of *Ahr* and *Pxr* is sexually dimorphic and rhythmic ([@bib104]). AHR expression and activity ([@bib132], [@bib159]) and *Pxr* expression are regulated by the circadian clock ([Figure S7](#mmc1){ref-type="supplementary-material"}A). In addition, the circadian clock regulated BA homeostasis ([@bib108]) and several microbiota-derived metabolites known to activate AHR and PXR displayed a sexually dimorphic diurnal accumulation ([Figure 5](#fig5){ref-type="fig"}I). Therefore, we evaluated if disruption of the circadian clock and its downstream regulation of xenobiotic receptors also lead to change in liver sexual dimorphism. *Cry1*/*Cry2* KO male mice exhibited a feminized liver transcriptome ([Figures 7](#fig7){ref-type="fig"}A and 7D). This feminization was also present in male *Bmal1* KO mice ([Figure 7](#fig7){ref-type="fig"}B). Interestingly, *Bmal1* KO mice show reduced GH levels as already shown for *Cry1*/*Cry2* KO ([@bib24]) ([Figure S7](#mmc1){ref-type="supplementary-material"}B). Furthermore, a mouse model of chronic jet lag exhibited a masculinized liver transcriptome ([Figures 7](#fig7){ref-type="fig"}C and 7D). Underlying activities of the AHR and PXR pathways in *Cry1*/*Cry2* KO mice were similar to the ones observed in GF mice ([Figures S7](#mmc1){ref-type="supplementary-material"}C and S7G), while *Bmal1* KO mice showed a decrease in the activities of both AHR- and PXR-dependent pathways ([Figures S7](#mmc1){ref-type="supplementary-material"}D and S7G), and chronic jet lag mice exhibited no clear regulations of these pathways ([Figures S7](#mmc1){ref-type="supplementary-material"}E and S7G). These data suggest that the dysregulation of AHR in clock mutants is likely involved in their feminized liver transcriptomes.Figure 7Sexual Dimorphism Is Attenuated in Clock-Deprived Mice, and Ghrelin Plays an Important Role in Sustaining Sexually Dimorphic Gene Expression(A--C) Changes in hepatic gene expression (log2FC) and adjusted p values of the clock-deprived models *Cry1*/*Cry2* KO (A) and *Bmal1* KO (B) compared with wild-type and chronically jet-lagged versus non-jet-lagged male animals (C) presented as a volcano plot. WT, wild-type.(D) Graph depicting the adjusted p value of the analysis assessing the enrichment of male- and female-biased genes in the different conditions shown in (A)--(C).(E--H) Ghrelin blunts the feminized expression signature of GF♂ mice. (E) Experimental design to evaluate the effect of ghrelin on hepatic sexually dimorphic gene expression. (F) Changes in hepatic gene expression (log2FC) and adjusted p values of ghrelin-injected GF♂ mice presented as a volcano plot. (G) Enrichment analysis of male- and female-specific genes (♂ biased, ♀ biased) or repressed or induced genes in GF mice (down or up in GF♂) for differentially expressed genes of the contrast ghrelin- versus vehicle-injected males. (H) The differences of differentially expressed sex-biased genes between GF and ConvR male mice are strongly attenuated by ghrelin injections (^∗∗∗^p \< 0.001, paired t test).(I) Working model for the control of sex-specific rhythmic gene expression and metabolism by microbiota.

To link these phenomena, we searched for a common pathway that might explain the observed phenotype in all described conditions and acting upstream of GH secretion. A likely candidate was ghrelin. GF mice have low ghrelin levels ([@bib127]), a characteristic shared in obese individuals ([@bib165]). Moreover, ghrelin secretion is stimulated by AHR activation ([@bib100]), whereas shift work ([@bib38], [@bib39]) and *Bmal1* deletion ([@bib86]) are associated with low and non-rhythmic ghrelin levels. Ghrelin has been shown to be an activator of GH secretion ([@bib77]), contributing to the amplitude of the secretion pattern ([@bib47], [@bib179]). In addition, ghrelin secretion is stimulated by testosterone ([@bib126]), whereas E2 inhibits ghrelin action in males ([@bib30]). Given the detected sex-hormone levels in GF mice, we hypothesized that ghrelin signaling alters GH secretion pattern in GF animals. We injected acetylated ghrelin in GF male mice and studied the impact on global hepatic sexual dimorphism. Ghrelin injection rescued the observed feminization of GF male mice, suggesting that ghrelin plays a key role in sustaining hepatic sexual dimorphism ([Figures 7](#fig7){ref-type="fig"}E--7H).

Discussion {#sec3}
==========

We have shown that the absence of microbiota leads to alterations in sex-dimorphic gene expression and metabolism. Moreover, we gained novel insights into female- and male-specific rhythms of gene expression and metabolites, which also depend on the presence of microbiota. Indeed, the absence of microbiota altered GH secretion and sexual maturation and, consequently, sexual dimorphism in gene expression. Interestingly, such attenuated sexual dimorphism was also found in obese or circadian clock-deprived mice. Altered microbiota conditions also showed a perturbed secretion of the GH-releasing factor ghrelin, and we showed that ghrelin injections could restore hepatic sexual dimorphism in GF mice, indicating an important role of ghrelin in the maintenance of sexual dimorphism.

We found that the absence of microbiota perturbed hepatic gene expression in rhythmic and sexually dimorphic pathways such as lipid and xenobiotic metabolism. Although the signals responsible for this phenomenon are not well characterized, a role of microbiome-derived signals has been suggested ([@bib90], [@bib115], [@bib145], [@bib161], [@bib168], [@bib186]). Here, we showed that sexual dimorphic gene expression and metabolism are altered in GF mice. Indeed, several metabolic characteristics of GF mice, such as reduced growth ([@bib180]), reduced body fat, liver lipogenesis, increased mitochondrial activity, insulin sensitivity ([@bib9]), increased brown adipose tissue ([@bib156]), and resistance to HFD-induced obesity ([@bib10], [@bib133]) are all hallmarks of feminized metabolism ([@bib110]). Also, sex bias in sexually dimorphic xenobiotic detoxification ([@bib20], [@bib149]) and male-prone liver cancer ([@bib55], [@bib169]) is lost in GF and young age-castrated animals. All of these sex-specific diseases showed altered sex-hormone regulation and GH signaling. Therefore, we hypothesized that activation of cell signaling pathways by microbiota-derived molecules during the prepubertal period is crucial for sexual maturation and downstream metabolism. Microbiota-derived metabolites such as butyrate and other short-chain FAs (SCFAs) potentiate GH secretion in the pituitary ([@bib113]) and its stimulating factor ghrelin ([@bib127]). Such regulation of secretion is potentially responsible for the low GH secretion in GF animals ([Figures 3](#fig3){ref-type="fig"}C and 3D). Consequently, GF mice displayed poor growth, paralleled by differences in the presence of SCFAs ([@bib180]), potentially through the impact of SCFAs on GH secretion.

We also identified other microbiota-activated pathways, besides GH signaling, which play crucial roles in sexual development. For example, *AhR* KO ([@bib67]) and *Fxr* KO ([@bib109]) mice suffer from defective sexual maturation. In addition, prenatal exposure to environmental pollutants that activate AHR or xenobiotic receptors leads to impaired sexual development in both mice and humans ([@bib50], [@bib140], [@bib141], [@bib128], [@bib178], [@bib187]). Interestingly, these so-called endocrine disruptors also affect GH secretion ([@bib1], [@bib158]) and the composition of the microbiome ([@bib94], [@bib119], [@bib189]). Altered circadian and sleep-wake rhythms are similarly associated with impaired sex-hormone secretion and gonadal development ([@bib3], [@bib114]), GH secretion ([@bib24], [@bib176]), alteration of microbiota ([@bib96], [@bib131], [@bib160], [@bib171]), and obesity and metabolic syndrome ([@bib85]). Similarly, genetic ([@bib49]) and HFD-induced obesity ([@bib146]) are associated with reduced pulsatile GH secretion, reduced sexual dimorphism of sex-hormone production, gonadal deficiency ([@bib45]), and altered gut microbiota ([@bib177]). We showed that GF mice ([Figures 6](#fig6){ref-type="fig"}E and [S6](#mmc1){ref-type="supplementary-material"}A), animals treated with antibiotics ([Figures S6](#mmc1){ref-type="supplementary-material"}F and S6G), circadian clock-deficient animals ([Figures S7](#mmc1){ref-type="supplementary-material"}C, S7D, and S7G), and mice fed with HFD ([Figures S7](#mmc1){ref-type="supplementary-material"}F and S7G) all show a blunted response to AHR and PXR activators. In addition, both AHR ([@bib190]) and PXR ([@bib168]) are involved in immune responses, which lose sex bias in GF mice ([@bib107], [@bib183]). The interplay between microbiota and sex-biased signaling pathways is schematized in a working model ([Figure 7](#fig7){ref-type="fig"}I).

Is this link between microbiome bacteria and sexual development conserved among animals throughout their evolution? Bacteria are known to influence sexual maturation in arthropods and nematodes. For example, *Wolbachia* and other non-pathologic parasites function as regulators of sex determination in insects ([@bib66]). Interestingly, pathways involved in nematode innate immunity, such as the DAF-2/DAF-16 pathway ([@bib53], [@bib134]), also regulate genes involved in xenobiotic detoxification, lipid metabolism, and stress resistance ([@bib118]) and can affect fertility ([@bib163]). Of note, these pathways are also associated with GH signaling. Moreover, the NHR-25 nuclear receptor, a sensor of microbial metabolites ([@bib98]), is involved in the sexual development of nematodes ([@bib54]). SF-1 and LRH-1, the mammalian homologs of NHR-25, PL receptors ([@bib82]) controlled by BA ([@bib103]), regulated intestinal immune response ([@bib36]) and sexual development ([@bib48]). Both PL and BA are modified by sex and microbiota ([Figures 5](#fig5){ref-type="fig"}F, [S4](#mmc1){ref-type="supplementary-material"}G--S4I, and [S6](#mmc1){ref-type="supplementary-material"}). Thus, NHR-25 homologs could also play a role in microbiota-associated sexual dimorphism. Since specific bacteria species can rescue the sexual performance of sterile flies ([@bib15]) and gonad development and reproduction in zebrafish ([@bib29]), it is likely that a role of the microbiota in sexual maturation is evolutionarily conserved.

Limitations of Study {#sec3.1}
--------------------

We found that the mouse microbiome plays a critical role in sexual dimorphism through the regulation of GH secretion and sexual maturation. While we provide evidence that microbiota-derived metabolites are likely involved in sustaining sexual dimorphism through the activation of the xenobiotic receptors AHR and PXR, the exact mechanism of their action remains elusive. Moreover, the implication of deficient ghrelin secretion in attenuated sexually dimorphic expression patterns that we describe for several conditions will be a topic for future studies. Despite the described limitations of our study, the importance of microbiota in sustaining sexual dimorphism is unexpected and might bear relevance for human perturbation of microbiota diversity at an early age.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**STAT5Cell Signaling TechnologyCat\# 9363S; RRID:[AB_10693321](nif-antibody:AB_10693321){#interref0355}Phospho-STAT5 (Tyr694)Cell Signaling TechnologyCat\# 9359S; RRID:[AB_823649](nif-antibody:AB_823649){#interref0360}BCL6Cell Signaling TechnologyCat\# 5650S; RRID:[AB_10949970](nif-antibody:AB_10949970){#interref0365}FOXA2Cell Signaling TechnologyCat\# 8186S; RRID:[AB_10892612](nif-antibody:AB_10892612){#interref0370}AMPKαCell Signaling TechnologyCat\# 2532; RRID:[AB_330331](nif-antibody:AB_330331){#interref0375}Phospho-AMPKα (Thr172)Cell Signaling TechnologyCat\# 2535; RRID:[AB_331250](nif-antibody:AB_331250){#interref0380}CUX2Thermo Fisher Scientific (Proteintech)\#24902-1-APanti-rGH (monkey)National Hormone & Peptide Program (NHPP)\#AFP-411S; RRID:[AB_2665564](nif-antibody:AB_2665564){#interref0385}rabbit antiserum to rGHNational Hormone & Peptide Program (NHPP)\#AFP-5641801Anti-rabbit IgG, HRP-linked AntibodyCell Signaling TechnologyCat\# 7074; RRID:[AB_2099233](nif-antibody:AB_2099233){#interref0390}**Chemicals, Peptides and Recombinant Proteins**rat acetylated GhrelinTocris\#1465recombinant human Growth HormoneBioVision\#4769mouse Growth HormoneNational Hormone & Peptide Program (NHPP)\#AFP-10783B**Critical Commercial Assays**Testosterone ELISA kitEnzo\#ADI-900-065Mouse/Rat Estradiol ELISACalbiotech\#ES180S-100MiSeq Reagent kit V2 (500 cycles)Illumina\#MS-102-2003QIAamp DNA Stool Mini KitQiagen\#51504miRNeasy Mini KitQiagen\#74106PE Cluster Kit v3 cBot-HSIllumina\#FC-401-3001TruSeq SBS Kit v3-HSIllumina\#PE-401-3001Ribo-Zero GoldIllumina\#RS-122-2303**Deposited Data**Raw and processed data (RNA-seq) of this paperGEO (<http://www.ncbi.nlm.nih.gov/geo/>)GEO: [GSE77221](ncbi-geo:GSE77221){#intref0015}Raw data (16S rRNA sequencing) of this paper<https://www.ncbi.nlm.nih.gov/sra>SRP151275Raw and processed data (Microarray); sexual dimorphism in white adipose tissue (male and female WAT)GEO (<http://www.ncbi.nlm.nih.gov/geo/>)GEO: [GSE3086](ncbi-geo:GSE3086){#intref0030}Raw and processed data (Microarray); germ-free mice vs conventionally raised (male liver)GEO (<http://www.ncbi.nlm.nih.gov/geo/>)GEO: [GSE53590](ncbi-geo:GSE53590){#intref0040}Raw and processed data (Microarray); germ-free mice on high-fat diet (male liver)GEO (<http://www.ncbi.nlm.nih.gov/geo/>)GEO: [GSE19038](ncbi-geo:GSE19038){#intref0050}Raw and processed data (RNA-seq); vertical sleeve gastrectomy on high-fat diet (male liver)GEO (<http://www.ncbi.nlm.nih.gov/geo/>)GEO: [GSE53782](ncbi-geo:GSE53782){#intref0060}Raw and processed data (RNA-seq); high-fat diet (male liver)GEO (<http://www.ncbi.nlm.nih.gov/geo/>)GEO: [GSE87565](ncbi-geo:GSE87565){#intref0070}Processed data (Microarray); resistant starch at high-fat diet (male liver)[@bib72]Available upon request from the authorsRaw and processed data (RNA-seq); *Bmal1* KO (male liver)GEO (<http://www.ncbi.nlm.nih.gov/geo/>)GEO: [GSE73554](ncbi-geo:GSE73554){#intref0080}Raw and processed data (Microarray); *Ahr* KO mice (male liver)GEO (<http://www.ncbi.nlm.nih.gov/geo/>)GEO: [GSE10082](ncbi-geo:GSE10082){#intref0090}Raw and processed data (Microarray); *Fxr* KO mice (male liver)GEO (<http://www.ncbi.nlm.nih.gov/geo/>)GEO: [GSE76162](ncbi-geo:GSE76162){#intref0100}Raw and processed data (Microarray); *Pxr* KO mice (male liver)GEO (<http://www.ncbi.nlm.nih.gov/geo/>)GEO: [GSE55746](ncbi-geo:GSE55746){#intref0110}Raw and processed data (RNA-seq); low-dose penicillin treatment (LDP) (male and female liver) and microbiota transfaunation after LDP treatment (female liver)GEO (<http://www.ncbi.nlm.nih.gov/geo/>)GEO: [GSE58089](ncbi-geo:GSE58089){#intref0120}Raw and processed data (RNA-seq); early-life pulsed antibiotic (amoxicillin/tylosin) treatment in (male liver)GEO (<http://www.ncbi.nlm.nih.gov/geo/>)GEO: [GSE68603](ncbi-geo:GSE68603){#intref0130}Raw and processed data (Microarray); germ-free mice with bacterial reconstitution at 5 weeks of ageCIBEX (<http://cibex.nig.ac.jp>)CIBEX: CBX256Raw and processed data (Microarray); chronic jet lagGEO (<http://www.ncbi.nlm.nih.gov/geo/>)GEO: [GSE75475](ncbi-geo:GSE75475){#intref0145}Broad single-cell transcriptome view of the male mouse germlineGEO (<http://www.ncbi.nlm.nih.gov/geo/>)GEO: [GSE104556](ncbi-geo:GSE104556){#intref0155}Raw and processed data; ChIP-seq FOXA1/FOXA2ArrayExpress (<https://www.ebi.ac.uk/arrayexpress/>)AE: E-MTAB-805Raw and processed data; ChIP-seq STAT5 and Bcl6 (male and female liver)GEO (<http://www.ncbi.nlm.nih.gov/geo/>)GEO: [GSE31578](ncbi-geo:GSE31578){#intref0170}Processed data; ChIP-seq CUX2 (female liver)[@bib32]Provided as [Supplemental Information](#app2){ref-type="sec"}Raw and processed data; ChIP-seq H3K4m1, H3K4m3, H3K9a, H3K27a, H3K27m3, H3K36m3, H3K79m2, CTCF, POLII (male liver)GEO (<http://www.ncbi.nlm.nih.gov/geo/>); [@bib44], [@bib150]GEO: [GSE29218](ncbi-geo:GSE29218){#intref0180}; GEO: [GSE31039](ncbi-geo:GSE31039){#intref0185}Raw and processed data; DNase I Seq (male and female liver)GEO (<http://www.ncbi.nlm.nih.gov/geo/>)GEO: [GSE21777](ncbi-geo:GSE21777){#intref0195}Raw and processed data; POLII ChIP-seq (male and female liver)GEO (<http://www.ncbi.nlm.nih.gov/geo/>)GEO: [GSE47899](ncbi-geo:GSE47899){#intref0205}Positional weight matrices of transcription factors (SwissRegulon)[@bib125]; <http://swissregulon.unibas.ch/fcgi/sr/downloads>N/AProcessed data; marker genes of germ cell differentiation in mouse testis[@bib105]N/ARaw data; mouse transcriptome of different tissues including oocytesGEO (<http://www.ncbi.nlm.nih.gov/geo/>)GEO: [GSE1133](ncbi-geo:GSE1133){#intref0220}Processed data; fetal germline cells stages to oocytes[@bib95]N/A**Experimental Models: Cell Lines**Mouse (CD-1) Cryopreserved Hepatocytes, Plateable FemaleThermo Fisher Scientific\#MSCP20Mouse (CD-1) Cryopreserved Hepatocytes, plateable maleThermo Fisher Scientific\#MSCP10**Experimental Models: Organisms/Strains**Conventionally raised mice (male and female) (C57BL/6 background)Charles River LaboratoriesC57BL/6JGerm free (male and female) (C57BL/6 background)University of Bern, CNRS TAAM, OrleansN/A*Cry1*/*Cry2* KO mice (C57BL/6 background)Prof. G. van der Horst (Erasmus University Medical Center, Rotterdam, the Netherlands)N/ASterile chow dietSAFE\#U8213G10R**Oligonucleotides**Forward_16S_rRNA:\
AATGATACGGCGACCACCGAGATCTACAC\
\[8 base barcode\]TATGGTAATTTGCCTACG\
GGNGGCWGCAG[@bib79]N /AReverse_16S_rRNA:\
CAAGCAGAAGACGGCATACGAGAT\
\[8 base barcode\] AGTCAGTCAGGCGACTACH\
VGGGTATCTAATCC[@bib79]N/ASeq_p\_Read1_V3 TATGGTAATTTGCCTACGG\
GNGGCWGCAG[@bib27]N/ASeq_p\_Read2_V4\
AGTCAGTCAGGCGACTACHVGGGTATCTAATCC[@bib27]N/ASeq_p\_Index2_V4\
GGATTAGATACCCBDGTAGTCGCCTGACTGACT[@bib27]N/A**Software and Algorithms**Mothur (v1.33.0)[@bib148]<https://www.mothur.org/>STAR (v2.5.3.a)[@bib40]<https://code.google.com/archive/p/rna-star/>QIIME (v1.8)[@bib26]<http://qiime.org/>DESeq2[@bib101][https://doi.org/10.18129/B9.bioc.DESeq2](10.18129/B9.bioc.DESeq2){#intref0240}Limma[@bib138][https://doi.org/10.18129/B9.bioc.limma](10.18129/B9.bioc.limma){#intref0245}MotEvo (v1.03)[@bib6]N/AMARA (custom implementation)[@bib12]Custom scriptsFiji[@bib147]<https://imagej.net/Fiji>Ingenuity Pathway Analysis (IPA)Qiagen<https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis>Enrichr[@bib84]<http://amp.pharm.mssm.edu/Enrichr/>RDAVIDWebService[@bib63][https://doi.org/10.18129/B9.bioc.RDAVIDWebService](10.18129/B9.bioc.RDAVIDWebService){#intref0265}R[@bib135]<https://www.r-project.org>SAMtools[@bib93]<http://www.htslib.org/>edgR[@bib139][https://doi.org/10.18129/B9.bioc.edgeR](10.18129/B9.bioc.edgeR){#intref0280}biomaRt[@bib43][https://doi.org/10.18129/B9.bioc.biomaRt](10.18129/B9.bioc.biomaRt){#intref0285}

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to the Lead Contact, Frederic Gachon (<f.gachon@uq.edu.au>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

The studies were conducted in accordance with the regulations of the Nestlé ethical committee and the veterinary office of the Canton of Vaud.

### Mouse Strains {#sec4.3.1}

C57BL/6J male and female GF and ConvR mice were kept in gnotobiotic isolators under diurnal lighting conditions (12-hr light 12-hr dark) at a temperature of 21°C ± 2°C. The mice had free access to a sterile chow diet (irridated with \>40 kiloGrays) and water. Sterility of GF animals was weekly assessed. All mice used in the experiments were between 9 and 16 weeks old. Liver, duodenum, jejenum, testis, ovaries, and perigonadal WAT were snap-frozen in liquid nitrogen and stored at −80° until further processing for RNA and protein extraction or fixed in formalin for histology.

### Primary Hepatocytes {#sec4.3.2}

Cryopreserved hepatocytes from a female or male CD-1 donor mouse were purchased from Thermo Scientific (\#MSCP10/20) and stored in liquid nitrogen before usage.

Method Details {#sec4.4}
--------------

### Growth Hormone Serum Kinetics {#sec4.4.1}

Pulsatile secretion of GH was assessed with 9 to 11 weeks old C57BL/6J mice. Twenty-five sequential blood samples (4 μL) were taken at 15 min intervals starting at ZT 0.5 for each individual mouse. GH was measured using an ELISA assay described below.

### Growth Hormone and Ghrelin Injections {#sec4.4.2}

Male GF animals received daily a subcutaneous injection with rat acetylated Ghrelin (10 μg/mouse) or PBS (at ZT 2) over a period of 5 days. Injections with recombinant human GH (50 μg/mouse) or PBS were applied twice a day (ZT 2 and ZT 14) over a period of 5 days.

### Phenotyping Studies {#sec4.4.3}

Activity and food intake was measured with an automated measurement system (Phenomaster, TSE) equipped with feeding and drinking sensors, infrared beam based activity monitoring system and ventilated isopositive HEPA cages systems. Prior to use, cages were disassembled and autoclaved. Electronic sensors for phenotypic measurements were sterilized with hydrogen peroxide, acetic acid, and peracetic acid vapors sterilization technique. Mice were transferred into sterile isopositive phenomaster cages and measurements were started after an acclimation period of at least 18 hr.

### Feces Collection for Microbiota Analysis {#sec4.4.4}

To assess gut microbiota diversity (16S rRNA Sequencing) we collected and froze fresh feces from male and female ConvR mice at the arrival (time point 1) of the animals from the provider and subsequently separated the animals into single cages. During the two following weeks, the bedding of the animals was mixed daily and distributed between all cages. Then, a second collection of feces was performed (time point 2).

### Serum and GH Treatment in Primary Hepatocytes {#sec4.4.5}

Cryopreserved hepatocytes were seeded into Collagen I coated 24-well plates (Thermo Scientific \#CM1024) (200,000 cells/well) and incubated in plating medium (Williams' E Medium supplemented with 5% Fetal Bovine Serum, 1 μM Dexamethasone, 1% Penicillin/Streptomycin, 4 μg/mL Human Recombinant Insulin, 2 mM GlutaMAX and 15 mM HEPES (pH7.4)) without further passaging. After a 6 hr incubation period to allow the cells to attach to the plate, medium was changed to a defined incubation medium (Williams E Medium supplemented with 0.1 μM Dexamethasone, 0.5% Penicillin/Streptomycin, 6.25 μg/mL human recombinant insulin, 6.25 μg/mL human transferrin, 6.25 ng/mL selenous acid, 1.25 mg/mL bovine serum albumin, 5.35 μg/mL linoleic acid, 2 mM GlutaMAX and 15 mM HEPES (pH7.4)) and a Geltrex matrix overlay (Thermo Scientific \#A1413201) was applied to the plated cells. The next day, the maintenance medium supplemented with 25% sterile-filtered serum from ConvR male, ConvR female or GF female mice was applied to the cells. After 24 hr cells were then either treated with 8 ng/mL mouse growth hormone or vehicle (PBS) for 2 hr before RNA extraction. Cells were kept at 37°C in a humidified atmosphere of 95% air and 5% CO~2~.

### Total Protein Extraction and Analysis {#sec4.4.6}

Frozen pieces of liver were homogenized in a 20 mM HEPES buffer (pH 7.6) supplemented with 100 mM KCl, 0.1 mM EDTA, 1 mM NaF, 1 mM sodium orthovanadate, 1% Triton X-100, 0.5% Nonidet P-40, 0.15 mM spermin, 0.5 mM spermidine, 1 mM DTT, and a protease inhibitor cocktail. Homogenates were incubated on ice for 30 min and then cleared by a 10 min centrifugation at 21,000 *g*. After fractionation by SDS-PAGE, 65 μg of the cleared protein extracts were transferred to a PVDF membrane for western blot analysis. Primary antibodies were used at the following dilutions: 1:500 (STAT5), 1:500 (Phospho-STAT5 (Tyr694)), 1:500 (BCL6), 1:1000 (FOXA2), 1:1000 (AMPKα), 1:1000 (Phospho-AMPKα (Thr172)), and 1:500 (CUX2).

### Measurement of MUPs Level in Urine {#sec4.4.7}

Urine was frozen after collection and stored at −80°C. Before usage, urine were cleared by a brief centrifugation (5 min at 9,000 *g*). 1 μL of the supernatant was fractionated by SDS-PAGE. Proteins were then visualized by Coomassie Blue staining. The level of MUPs was analyzed by quantifying the bands at a size of approximately 20 kDa.

### Hormonal Assays {#sec4.4.8}

Circulation free testosterone and E2 were measured with commercially available ELISA kits ([Key Resources Table](#sec4.1){ref-type="sec"}) following the manufacturers' protocols. Serum levels of GH were determined with a sandwich ELISA as described ([@bib155]). Specifically, a 96-well plate was coated with anti-rGH (monkey) as a capture antibody at a dilution of 1:40,000 and incubated overnight at 4°C. The next day, wells were blocked with blocking buffer (5% skim milk powder diluted in 0.05% PBS with Tween-20). After blocking, samples and standards (mouse Growth Hormone) were applied to each well. The bound standards and samples were then incubated with the detection antibody (rabbit antiserum to rGH (1:40,000)). The bound sandwich complex was incubated was anti-rabbit HRP conjugated antibody at a final dilution of 1:2,000. O-phenylenediamine served as a substrate of the enzymatic colorimetric rection which was stopped by adding HCl. Absorbance was measured at 490 nm. Secretion peaks were defined by a minimal two-fold increase in GH between two consecutive time points.

### Microbiota Analysis by 16S rRNA Genes Sequencing {#sec4.4.9}

16S rRNA genes analysis was performed as described elsewhere ([@bib73]). Specifically, mouse feces were mechanically disrupted before DNA extraction. The V3 to V4 region of the 16S rRNA gene was amplified with region specific primers that included the Illumina flowcell adapter sequences and barcode sequences for dual indexing with 8 nt ([Key Resources Table](#sec4.1){ref-type="sec"}) following the suggestions of [@bib79]. After equimolar pooling, the PCR products were purified using magnetic beads Agencourt AMPure XP (Beckman Coulter). Library was quantified with a QuBit Fluorometer (ThermoScientific). The purified pool (10 nM) was sequenced in paired end (2^∗^250 cycles) on the MiSeq Illumina sequencer using the MiSeq Reagent kit V2 500 cycles as suggested in [@bib27]. Paired-end sequences were joined and chimera sequences were removed using Mothur V.1.33.0 ([@bib148]). We used QIIME V.1.8 ([@bib26]) to generate and annotate Operational Taxonomic Units (OUT) at 97% identity. A phylogenetic tree was built on the multiple alignment of the OTU representative sequences. Phylogenetic distances between samples were computed as weighted UniFrac distances ([@bib102]) to calculate the principal coordinates using QIIME. Then, we defined the variance explained by individuality and sex using Adonis tests on the weighted UniFrac distances in QIIME.

### Histology {#sec4.4.10}

Mouse testes and ovaries were fixed 24 hr with 10% formalin (Sigma-Aldrich), rinsed twice with PBS and then embedded in paraffin and cut into 4 mm thick sections. Tissue sections were deparaffinized, rehydrated in ethanol series and then washed with phosphate buffered saline PBS. Cell nuclei and polysaccharide staining was done with Mayer's hematoxylin and Periodic Acid Schiff solution, respectively, using a Tissue-Tek Prisma autostainer from Sakura linked to a G2-coverslipper. The following reagents were used: 1% Periodic acid in water, Schiff reagent (Bio-Optica) and Hématoxyline solution (Harris Gill II PAP1Biosystems). The program is summarized below. Imaging was performed with an Olympus slide scanner at 20x magnification and pictures were analyzed using Fiji.StepStationSolutionTimeDelayMix1S^∗^Start Station\--:\--:\--2D^∗^Drying Station00:10:00^∗∗^OFF344Xylene00:03:00^∗∗^OFF442Xylene00:03:00^∗∗^OFF540Xylene00:03:00^∗∗^OFF638Ethanol 100%00:01:00^∗∗^OFF736Ethanol 100%00:01:00^∗∗^OFF834Ethanol 96%00:01:00^∗∗^OFF933Ethanol 70%00:01:00^∗∗^OFF10W^∗^Wash Station00:01:00^∗∗^EW1135A. dest.00:00:30^∗∗^OFF1239Periodic Acid00:05:00==ON13W^∗^Wash Station00:04:0050%EW1437A. dest.00:01:00^∗∗^EW1521Schiff\'s00:15:00==ON16W^∗^Wash Station00:10:0050%EW1718A. dest.00:00:30^∗∗^OFF184Hematoxylin00:05:00==ON19W^∗^Wash Station00:00:30^∗∗^EW206Acid Alcohol00:00:03==ON21W^∗^Wash Station00:10:00^∗∗^EW221Ethanol 70%00:01:00^∗∗^OFF232Ethanol 96%00:01:00^∗∗^OFF2415Ethanol 100%00:01:00^∗∗^OFF2516Ethanol 100%00:02:00^∗∗^OFF2631Xylene00:01:00^∗∗^OFF2732Xylene00:01:00^∗∗^OFF28E^∗^End Station\--:\--:\--

### RNA Extraction and Total RNA Sequencing {#sec4.4.11}

Liver RNA was extracted as previously described ([@bib51]). Approximately 100 mg of frozen liver was grinded in extraction buffer (3.9 M Guanidium thiocyanate, 0.03 M Sodium citrate, 0.2 M Sodium acetate, 1% (v/v) 2-Mercaptoethanol) using a Polytron PT 2500 E homogenizer. An equal volume of phenol (saturated in H2O) and 0.5 volume of chloroform/isoamylalcohol (49:1 (v/v)) were added to the homogenate. The mixture was vigorously vortexed subsequently. Phase separation was accomplished by a centrifugation step at 4°C 12,000 *g* for 20 min. RNA of the aqueous phase was precipitated at −20°C during at least 20 min using an equal volume of isopropanol. The precipitate was pelleted by centrifugation at 12,000 *g* for 15 min at 4°C. Subsequently, the pellet was resuspended in 4M LiCl and subsequently re-pelleted during a centrifugation step of 12,000 *g* for 15 min at 4°C. The pellet was washed with 75% ethanol with a subsequent centrifugation at 12,000 *g* for 15 min at 4°C. The washed pellet was then dried at room temperature and dissolved in RNAse/DNAse free water. Frozen duodenum, ileum, testis, ovary, and perigonadal WAT were homogenized in Qiazol with the help of a tissue lyser II (Qiagen). Primary hepatocytes were directly lysed in Qiazol as recommended by the manufacturer. Subsequently, RNA was extracted using the miRNeasy Mini Kit following the manufacturer\'s protocol. Total RNA was quantified with Ribogreen (Life Technologies) and quality was assessed on a Fragment Analyzer (Advances Analytical). Sequencing libraries were prepared from 250 ng total RNA using the TruSeq Stranded Total LT Sample Prep Kit with the Ribo-Zero Gold depletion set. The procedure was automated on a Sciclone NGS Workstation (Perkin Elmer). The manufacturer's protocol was followed, except for the PCR amplification step. The latter was run for 12 cycles with the KAPA HiFi HotStart ReadyMix (Kapa BioSystems). This optimal PCR cycle number was evaluated using the Cycler Correction Factor method as previously described ([@bib7]). Purified libraries were quantified with Picogreen (Life Technologies) and the size pattern was checked with the DNA High Sensitivity Reagent kit on a LabChip GX (Perkin Elmer). After being pooled, 24 libraries were clustered at a concentration of 7 pmol on 8 lanes of a v3 paired-end sequencing flow cell (Illumina). Sequencing was performed for 2 x 100 or 2 x 125 cycles on a HiSeq 2500, following Illumina's recommendations.

### Metabolic Profiling {#sec4.4.12}

Frozen serum aliquots and liver pieces were analyzed by Metabolon as described previously ([@bib46]). Specifically, samples were prepared using an automated MicroLab STAR system (Hamiliton Company). Methanol was added to the samples for protein precipitation. After centrifugation, the supernatant split into sufficient number of aliquots in order to measure them using four different Ultrahigh Performance Liquid Chromatography-Tandem Mass Spectroscopy (UPLC-MS/MS) methods. Organic solvent was subsequently removed using a TurboVap (Zymark) from the subsamples. The sample extracts were stored overnight under nitrogen before preparation for analysis. Sample extract were reconstituted in solvents compatible to each of the four methods. All methods were run on a Waters ACQUITY UPLC and a Thermo Scientific Q-Exactive high resolution/accurate mass spectrometer interfaced with a heated electrospray ionization (HESI-II) source and Orbitrap mass analyzer operated at 35,000 mass resolution.(1)The first method was optimized for hydrophilic compounds using acidic positive ion conditions. Here, the extract was gradient eluted from a C18 column (Waters UPLC BEH C18-2.1x100 mm, 1.7 μm) using water and methanol, containing 0.05% perfluoropentanoic acid (PFPA) and 0.1% formic acid (FA).(2)Hydrophobic compounds were the focus of the second method. Using the same C18 column (see 1) the extract was gradient eluted using methanol, acetonitrile, water, 0.05% PFPA and 0.01% FA at an overall higher organic content compared to method 1.(3)Method 3 used basic negative ion with optimized conditions using a dedicated separate C18 column. Using methanol and water with 6.5mM Ammonium Bicarbonate at pH 8, basic extracts were gradient eluted from the column.(4)The fourth method used a negative ionization with a subsequent elution from a HILIC column (Waters UPLC BEH Amide 2.1x150 mm, 1.7 μm). To this end, a gradient consisting of water and acetonitrile was used with 10 mM Ammonium Formate, pH 10.8. For all methods the scan range was between 70 and 1000 m/z.

### Metabolomics Data Processing and Analysis {#sec4.4.13}

We restricted the downstream analysis to metabolites that were detected in at least 6 samples of an experimental group. Data were median normalized for each metabolite and missing values were imputed by k-nearest neighbors yielding a relative quantification of each metabolite. A two-factor linear model was fitted with the factors sex and hygiene status and applied to log2-transformed metabolite levels. In order to compare the means of specific contrasts (i.e. GF male vs. ConvR male, GF female vs. GF female, ConvR male vs. ConvR female and GF male vs. GF female) were used to make specific comparisons of treatments within a linear model. The retrieved p values were corrected for multiple testing ([@bib17]). In order to assess changes on a pathway level, we employed a simple statistical approach based on aggregated z-scores as described ([@bib81]). Specifically, relative metabolite levels across all samples were transformed into z-scores. Z-scores of all metabolites sharing a specific sub- or super pathway were averaged. These values were used as a proxy for average activity in that specific pathway for each sample. The averaged z-scores were subjected to the same linear regression analysis used for single metabolites.

### RNA-Seq Data Processing {#sec4.4.14}

Paired-end reads were mapped onto the Ensembl *Mus musculus* genome annotation (GRCm38/mm10) using STAR 2.3.8 ([@bib40]). Uniquely mapped reads were counted for each gene locus as described ([@bib7]). Specifically, using a custom Perl script we applied SAMtools view ([@bib93]) to assigned unique mapped paired-end reads to exons considering read orientation. The count data were normalized by size factor and a variance stabilizing transformation was applied for downstream analysis. Differential gene expression was assessed by DESEq2 ([@bib101]). Data from other RNA-seq based studies that were used for subsequent gene set enrichment analysis were retrieved from indicated sources in [Key Ressources Table](#sec4){ref-type="sec"} and analyzed as described above.

### Microarray Data Processing {#sec4.4.15}

Liver expression microarray data from other studies were retrieved from the indicated sources ([Key Resources Table](#sec4.1){ref-type="sec"}) and reanalyzed using the statistical package *limma* ([@bib138]). Annotation was retrieved from biomaRt ([@bib43]) or, if not available, we used the annotation provided by the indicated repository. In case of probes hitting the same gene, the most significant probe was selected for further analysis. We applied a basic differential gene expression analysis comparing two conditions (e.g. antibiotica treated vs untreated, HFD vs chow diet). Statistical analysis and differential expression were assessed using an empirical Bayes method ([@bib138]).

### Functional and Gene Set Enrichment Analysis {#sec4.4.16}

Analysis for functional enrichment were performed with Ingenuity Pathway Analysis (Qiagen), Enrichr ([@bib84]), and RDAVIDWebService ([@bib63]). For the latter, we calculated enrichment for GO terms for biological processes and KEGG pathway annotations. p values were adjusted for multiple testing ([@bib17]). To perform gene set enrichment analysis for sex-biased genes and TFs target genes, we employed the geneSetTest function of the *limma* package on a pre-ranked gene lists defined according to the *DESeq2* or *limma* results for RNA-seq-derived or microarray-derived datasets, respectively. Gene sets were derived from several sources: gene sets for *Ahr*, *Fxr*, and *Pxr* KO regulated genes are derived from the list of differentially expressed genes from the indicated datasets ([Key Resources Table](#sec4.1){ref-type="sec"}). The gene set list of sexually dimorphic liver genes is based on the comparison between ConvR males and ConvR females. Sexually dimorphic genes for WAT were derived from the indicated reanalyzed microarray dataset ([Key Resources Table](#sec4.1){ref-type="sec"}). Genes that show significantly different expression patterns (adjusted p value ≤ 0.05 and log2 fold change \> 0.5) between males and females were considered as male and female-biased, respectively. Public available ChIP-seq data were used to define downstream target gene sets of BCL6, STAT5, FOXA1/2, and CUX2 ([Key Resources Table](#sec4.1){ref-type="sec"}). We tested whether these gene sets are enriched in the up- or downregulated genes of the indicated comparisons. If neither of the alternatives showed a significant tendency, we tested whether the genes in the set tended to be differentially expressed without regard for direction (mixed).

### *Bcl6* Locus Analysis {#sec4.4.17}

#### Density Profile {#sec4.4.17.1}

Density of reads along the *Bcl6* locus was computed for each sample. Briefly, paired-end reads mapped uniquely in the *Bcl6* region with no mismatch were used. Samtools with \"view\" parameter was called on the bam files to retrieve position of the reads and mapping length. For each pair of reads, the nucleotides corresponding to the respective mapped sequence (position + mapping length) were incremented of one count in a strand specific manner. Total counts were normalized by total library size, size correction factor and an arbitrary constant (10^6^) to improve readability using edgeR ([@bib139]). Median of the signal for each condition is reported after smoothing with a moving average of 50 nucleotides.

#### Correlation {#sec4.4.17.2}

Correlation matrix between the different features of the *Bcl6* locus was computed and depicted using the *corrplot* R package ([@bib175]) across the liver samples. Correlation (Pearson coefficient) was considered as significant if its respective p value was below 0.01 (Fisher's Z transform).

#### Genome-Wide Sense-AS Analysis {#sec4.4.17.3}

In order to detect genes with similar response pattern as *Bcl6* in the sense-antisense signal, we performed a genome-wide differential analysis of the sense-AS signal in liver. Uniquely mapped reads were counted for introns and exons features using SAMtools view option on the bam file as described above (density profile). The respective sense and AS reads counts were reported separately. Sum of exonic regions was used for the respective sense read counts while the sum of exonic and intronic reads count was used for the respective AS read counts. Reads counts were normalized using library size factor and differential expression between the different conditions was assessed using the general linear model framework of EdgeR ([@bib139]). In order to avoid false positive candidates, a strict genes selection based on reads count were applied. Genes with less average reads count on the respective sense signal than antisense signal were discarded. Genes with an average of at least 100 read counts in GF or ConvR mice for sense and AS were selected. Finally, genes with ratio sense/AS larger than 10 were discarded. Likelihood ratio test was applied by the glmLRT() function in EdgeR to test for the interaction term between strand (sense, AS) and conditions (e.g Male, Female) as described ([@bib52]). FDR was computed using the topTags() function with Benjamini and Hochberg correction ([@bib17]).

### Motif Activity Analysis {#sec4.4.18}

For predictions of TF binding sites near promoters, we used MotEvo version 1.03 ([@bib6]) to scan ± 500 bp around the TSS. We used promoters ([@bib11]) and weight matrices of TFs defined by SwissRegulon ([@bib125]) (<http://swissregulon.unibas.ch/fcgi/sr/downloads>). We applied a penalized regression model as previously described ([@bib12]) which uses an L2 penalty, allowing an estimate of the standard deviations.

### Rhythmicity Assessment in Different Experimental Groups {#sec4.4.19}

The rhythmicity of gene mRNA levels and metabolites in male and female GF or ConvR mice were assessed as described ([@bib7]). This method is based on multiple linear regression and a subsequent models selction that is based on the Bayesian information criterion. The full model is y(t) = μ + αcos((2π/24 h)t) + βsin((2π/24 h)t) + noise (y is the normalized and variance stabilized data, μ is mean, t is *Zeitgeber* time, α and β are the coefficients of the cosine and sine functions, respectively). Rhythmicity was compared across the different conditions (e.g. hygiene status and sex), we defined different model for two (GF and ConvR) or four conditions (GF female, ConvR female, GF male and ConvR male). Models were defined to have either zero (non-rhythmic pattern) or non-zero (rhythmic pattern) α and β coefficients for each analyzed condition. Moreover, for some models the values of α and β can be also shared within any combination of the two or four conditions. We used α and β to determine phase $\left( {arctan\left( \frac{\beta}{\alpha} \right)} \right)$ and log2 peak-to-trough amplitude as $\left( {2\sqrt{\alpha^{2} + \ \beta^{2}}} \right)$ of gene expression. Linear regression was used to solve each of the defined models. We used a BIC based model selection to consider model complexity ([@bib68]) ${BIC} = n \cdot \ln\left( \frac{\mathit{RSS}}{n} \right) + k \cdot \ln\left( n \right)$ (RSS is the residual sum of squares of the linear regression, *n* is the number of time points and *k* is the number of parameters). To assess the confidence of the selected model we calculated the Schwarz weight using the formula $\mathit{BICW} = \ \frac{\mathit{e}^{\frac{1}{2}\Delta\mathit{BI}\mathit{C}_{\mathit{j}}}}{\sum_{\mathit{M}}\mathit{e}^{\frac{1}{2}\Delta\mathit{BI}\mathit{C}_{\mathit{m}}}}$, with $\Delta\mathit{BI}\mathit{C}_{\mathit{j}}\mathit{=BI}\mathit{C}_{\mathit{j}} - \ \mathit{BI}\mathit{C}_{\mathit{m} \ast}$. Genes that did not reach a BIC weight (BICW) above 0.4 were categorized as "ambiguous" (model 0). Genes that were identified as having an alteration in amplitude or phase between GF and ConvR mice were subdivided into groups of strongly altered, mildly altered, only altered in phase and only altered in amplitude. Modification was considered mild if the change was less than 4 hr for the period or less than 2 fold in amplitude between the two conditions.

Data and Software Availability {#sec4.5}
------------------------------

The accession number for the entire RNA-seq dataset reported in this manuscript is [GSE77221](ncbi-geo:GSE77221){#intref0300}. To ease accessibility, we divided the data into the following subseries: (1) Temporal profile of GF and ConvR male and female mice (duodenum and ileum -- [GSE114399](ncbi-geo:GSE114399){#intref0305}, liver -- [GSE114400](ncbi-geo:GSE114400){#intref0310}, WAT -- [GSE114401](ncbi-geo:GSE114401){#intref0315}). (2) Temporal profile of Liver of *Cry1*/*Cry2* KO mice ([GSE114402](ncbi-geo:GSE114402){#intref0320}). (3) GF male mice liver injected with GH ([GSE114610](ncbi-geo:GSE114610){#intref0325}). (4) GF male mice liver injected with Ghrelin ([GSE114611](ncbi-geo:GSE114611){#intref0330}). (5) Testes and ovaries of ConvR and GF female mice ([GSE114612](ncbi-geo:GSE114612){#intref0335}). (6) GH and mouse serum treatment on primary hepatocytes ([GSE114613](ncbi-geo:GSE114613){#intref0340}). 16s rRNA data have been deposited on the SRA database under the reference SRP151275.

Quantification and Statistical Analysis {#sec4.6}
---------------------------------------

If not otherwise stated, statistical analysis comparing the means between experimental groups (ConvR male, GF male, ConvR female and GF female) was performed with one-way analysis of variance (ANOVA) followed by the Holm multiple comparison test comparing selected comparisons (ConvR male vs. GF male, ConvR male vs. ConvR female, ConvR female vs. GF female and GF male vs. GF female) using R ([@bib135]). Intersecting gene sets were visualized using the R-package *UpSetR* ([@bib91]). All data are expressed as mean ± standard error of the mean (SEM) if not otherwise stated.

Supplemental Information {#app2}
========================
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